Delivery Order SPE2DE21D7020-SPE2D626F4934
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $29,701.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by October 23, 2025, and represents work to be performed at the contractor's facility in Marlborough, MA. The award was issued without small business set-aside provisions, allowing...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,580.66 by the Defense Health Agency's Medical Supply Chain division on October 24, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, is scheduled for completion by October 31, 2025. This delivery order is issued without a small business set-aside, allowing Boston Scientific to compete on an...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,104.60 under a Blanket Purchase Agreement with the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as 4569783311 NC EMERGE MR 15MM, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 28, 2025. The award was issued without a small business set-aside, allowing...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,120.00 by the Defense Health Agency's Medical Supply Chain division. The contract, issued on June 30, 2025, with an ultimate completion date of July 11, 2025, covers NRG EEPROM high flow 98cm medical equipment under a fixed-price contract with economic price adjustment terms. The place of performance is Boston Scientific's facility in...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,688.80 by the Defense Health Agency's Medical Supply Chain division on September 29, 2023, with an ultimate completion date of October 6, 2023. This fixed-price delivery order with economic price adjustment was issued against an established Blanket Purchase Agreement (BPA) and carries no small business set-aside designation. The contract represents Boston Scientific's continued role...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,909.04 by the Defense Health Agency's Medical Supply Chain division on October 23, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is for the supply of specialized medical equipment identified as "4569832175 ! BLN 2.5MM 100MM 10MM WOLVERINE MNRL CUT." The delivery order will...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp has been awarded a delivery order valued at $4,774.65 by the Defense Health Agency's Medical Supply Chain division for the delivery of next-generation synthetic medical devices. The contract, awarded on October 22, 2025, with an ultimate completion date of October 29, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. Performance will take place at Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical device manufacturer headquartered in Marlborough, Massachusetts, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on September 29, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $3,362.95 and is scheduled for completion by October 6, 2025. The contract represents a single delivery order under Boston Scientific's established relationship with the Defense Health Agency and does not...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F4934Delivery Order
The Defense Health Agency's Medical Supply Chain division awarded a $4,320 fixed-price delivery order with economic price adjustment to Boston Scientific Corp for NRG EEPROM high-flow equipment (98 cm configuration), with an ultimate completion date of October 31, 2025. This delivery order, issued on October 24, 2025, will be performed in Marlborough, Massachusetts, and represents work under Boston Scientific's existing blanket purchase agreement with the Defense Health Agency. The award includes no small business set-aside, allowing Boston Scientific to compete on an unrestricted basis as the established vendor for specialized radiation treatment devices and related oncology equipment. Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, holds a single-award blanket purchase agreement valued at $750,000 with the Defense Health Agency through March 30, 2030. The company serves as the primary federal supplier of radiation treatment devices, including yttrium-90 glass microspheres and radiopharmaceuticals used across military healthcare facilities and Veterans Affairs medical centers. This delivery order exemplifies the streamlined procurement structure through which the Defense Health Agency issues task orders against the established indefinite delivery vehicle, enabling rapid resupply of critical cancer treatment modalities essential to the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 10/24/25 |